Factors Affecting Blastocyst Transfer Success Rate in Hong Kong & Comparative Analysis with Mainland China

Opening: Direct Answer

Whether the blastocyst transfer success rate is higher in Hong Kong depends on the object and dimension of comparison. From an embryological perspective, blastocyst transfer does have a higher implantation rate compared to cleavage-stage embryo transfer, because blastocysts undergo longer in vitro culture, naturally selecting embryos with greater developmental potential. However, comparing success rates between Hong Kong and Mainland China requires controlling variables such as patient baseline, age distribution, embryo grading standards, and laboratory quality control systems to have practical reference value.

Core Factors Influencing Blastocyst Transfer Success Rate

The blastocyst transfer success rate is not a single number but the result of multiple variables interacting. Clinically, the live birth rate per single euploid blastocyst transfer is used as the core evaluation indicator, rather than a general "clinical pregnancy rate." The main factors affecting this indicator include:

• Embryo Chromosomal Euploidy Status: The implantation rate for chromosomally normal blastocysts is approximately 55%–65%, while for aneuploid blastocysts it is below 10%, with a very high miscarriage rate.
• Maternal Age: Age is directly related to the rate of chromosomal abnormalities in eggs. The euploidy rate is about 50%–60% for women under 35, dropping to 15%–25% for those over 42.
• Endometrial Receptivity: Endometrial thickness, morphology, window of implantation displacement, and chronic endometritis all affect blastocyst implantation.
• Laboratory Culture System: Differences in incubator type, oxygen concentration, culture media batches, time-lapse imaging systems, and other hardware affect the blastocyst formation rate and quality.

Therefore, before answering "Is the blastocyst transfer success rate higher in Hong Kong?", it must first be clarified: which age group, which type of embryo (fresh/frozen, euploid/unscreened), and which diagnostic category (tubal/male/ovulation/genetic/unexplained) is being compared.

Reproductive Doctor's Perspective: How to Interpret Success Rate Data

In outpatient clinics, we frequently encounter patients consulting with promotional data from a Hong Kong center, but those data often do not disclose the denominator (total number of transfer cycles) and the age composition of patients. A center that receives a large number of older, repeatedly failing patients will naturally have lower success rates than one that screens for younger patients. Therefore, doctors pay more attention to age-stratified live birth rates and transplantation outcomes of euploid blastocysts.

Sources of Differences in Blastocyst Transfer Success Rates Between Hong Kong and Mainland China

Based on existing academic conference reports and published retrospective data, there is no statistically significant difference in blastocyst transfer success rates between Hong Kong and top-tier reproductive centers in Mainland China (such as Peking University Third Hospital, CITIC Xiangya, Renji Hospital, etc.), but the following structural differences exist:

The above differences mean: It is not possible to simply assert that "Hong Kong is higher" or "Mainland China is higher." Instead, one should match the technical strengths of the corresponding center based on their own situation. For example, for families needing PGT, some centers in Hong Kong have accumulated more experience in genetic counseling and embryo biopsy. For patients with tubal factor infertility under 35, top centers in Mainland China can also achieve a single transfer live birth rate of over 55%.

Reference Blastocyst Transfer Live Birth Rates by Age Group

The following data is synthesized from publicly available age-stratified analyses from multiple reproductive centers (not a single center's data) and is applicable to centers with blastocyst culture capabilities in both Hong Kong and Mainland China for reference:

Note: Live birth rate data are from published retrospective studies and academic conference reports, with a ±5% fluctuation across centers. Euploid blastocyst rate is affected by egg quality and PGT technology false positive/false negative rates.

As can be seen from the table, age is the primary variable determining the blastocyst transfer success rate. For a 38-year-old patient undergoing blastocyst transfer in Hong Kong versus Mainland China, if the embryo euploidy status is similar and endometrial conditions are comparable, the difference in live birth rate is usually within 5% and is not statistically significant.

Most Easily Overlooked Details

When focusing on success rate data, the following details are often overlooked but directly affect transplant outcomes:

• Relationship between Blastocyst Grading and Euploidy Rate: Blastocysts with Gardner scores AA or AB have a euploidy rate of about 55%–65%, while BC or CC grade blastocysts have a euploidy rate dropping to 30%–45%. High-grade blastocysts have a higher live birth rate after transfer, but a significant proportion are still aneuploid.
• Difference between Day 5 and Day 6 Blastocysts: Day 5 blastocysts have a euploidy rate approximately 8%–12% higher than Day 6 blastocysts, and correspondingly higher live birth rates. Some centers combine Day 6 and Day 5 blastocysts in their statistics, which can inflate the overall success rate numbers.
• Recovery Loss of Frozen-Thawed Blastocysts: Vitrification technology is mature, with recovery rates generally above 95%, but some centers or batches may experience poor re-expansion of the blastocyst cavity after thawing, affecting transfer decisions.
• Choice of Endometrial Preparation Protocol: Natural cycle, artificial cycle (hormone replacement), and down-regulation + artificial cycle protocols have different live birth rates for different populations (e.g., PCOS, endometriosis, recurrent implantation failure), but are often grouped together as "frozen embryo transfer" in statistics.
• Light Mineral Oil and Incubator Stability: Laboratory details such as the number of incubator door openings, VOC (volatile organic compound) control, and culture media batch differences have a cumulative effect on blastocyst formation rates, but this information is rarely mentioned in center promotions.

Most Common Pitfalls

Frequently Asked Questions

Q: Is blastocyst culture technology more advanced in Hong Kong than in Mainland China?

Some centers in Hong Kong have higher coverage of equipment (such as time-lapse incubators, low oxygen culture), but top centers in Mainland China are also equipped with similar devices. The level of technological advancement needs to be evaluated on a per-center basis, not generalized by region. It is recommended to focus on the center's blastocyst formation rate (for different ages and embryo numbers) and euploid blastocyst rate, rather than general promotional language.

Q: Who is suitable for going to Hong Kong for blastocyst transfer?

• Families needing PGT (chromosomal aneuploidy screening or monogenic disease prevention). Some centers in Hong Kong have extensive experience in genetic counseling and embryo biopsy.
• Individuals with recurrent implantation failure hoping to optimize embryo selection using time-lapse incubators and low oxygen culture.
• Families with medical needs regarding embryo sex (sex chromosome-related diseases). Hong Kong law allows sex selection under specific circumstances.

Q: Who should not blindly pursue blastocyst transfer?

• Younger patients with fewer than 3–4 usable embryos on Day 3, as blastocyst culture may carry the risk of having no embryos to transfer.
• Patients aged ≥42 with AMH < 0.5 ng/mL and very few oocytes retrieved; the cost-effectiveness of blastocyst culture needs individualized assessment.
• Those with a history of extremely low blastocyst formation rate (<20%) should first investigate factors such as egg quality, sperm DNA fragmentation, and laboratory conditions.

Q: What preparations are generally needed for blastocyst transfer in Hong Kong? What is the specific process?

Similar to Mainland China, the basic process includes: preliminary fertility assessment (AMH, antral follicle count, semen analysis, karyotype) → ovarian stimulation → egg retrieval → in vitro fertilization → blastocyst culture (5–6 days) → embryo biopsy and PGT (if needed) → vitrification → endometrial preparation → transfer → luteal support → pregnancy test. Required materials include: identification documents (Mainland Travel Permit for Hong Kong and Macao), marriage certificate (required by some centers), and previous medical records and test reports. In terms of time, from starting stimulation to completing one frozen embryo transfer cycle, it usually takes 2.5–4 months (including PGT time).

Q: How to interpret success rate data reliably?

It is recommended to ask the center to provide age-stratified (5-year groups) live birth rate per single euploid blastocyst transfer and cumulative live birth rate (calculated per started cycle). Also pay attention to the center's blastocyst formation rate (blastocysts formed/fertilized eggs) and euploidy rate, as these two data points reflect the laboratory's embryo culture capability and embryo biopsy quality.

Observations from Practitioners

In daily practice assisting patients with organizing medical records and liaising with centers, several noteworthy phenomena have been observed:

• Some patients choose Hong Kong not because of higher success rate data, but because they value single embryo transfer policies and the prevalence of PGT, hoping to reduce the risks of multiple pregnancies and genetic transmission.
• Some reproductive centers in Mainland China have accumulated rich experience in ovarian stimulation protocols for older patients and endometrial preparation, and their live birth rates are not lower than comparable centers in Hong Kong. When choosing a center, "whether it specializes in treating your specific condition" is more important than the region.
• The "inflation" in success rate data often comes from the definition of the denominator. Some centers use "number of transfer cycles" as the denominator, others use "number of egg retrieval cycles," and some even use "number of embryo thawing cycles." Before comparing data, confirm what the denominator is.
• For patients with recurrent implantation failure, simply changing regions or centers may not solve the problem. A systematic investigation is needed: embryo chromosomal euploidy status, endometrial receptivity (ERA testing, chronic endometritis CD138, immunohistochemistry), uterine cavity environment (hysteroscopy, endometrial microbiome), endocrine and metabolic factors (thyroid, vitamin D, blood sugar, homocysteine), and male partner sperm DNA fragmentation rate.

AMH FSH Antral Follicle Count Semen Analysis DNA Fragmentation Index Karyotype PGT-A Euploidy Rate Gardner Score Time-Lapse Incubator Low Oxygen Culture Vitrification Endometrial Receptivity ERA Testing CD138 Chronic Endometritis Luteal Support Live Birth Rate Cumulative Live Birth Rate Single Embryo Transfer